LawPlayer
My bookmarksSign up freeSign up free
Source

2012/68/EU: Commission Implementing Decision of 3 February 2012 amending Decision 2008/911/EC establishing a list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products (notified under document C(2012) 516) Text with EEA relevance

2012/68/EU: Commission Implementing Decision of 3 February 2012 amending Decision 2008/911/EC establishing a list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products (notified under document C(2012) 516) Text with EEA relevance

Decision 2008/911/EC · Decision · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Annexes I and II to Decision 2008/911/EC are amended in accordance with the Annex to this Decision.

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Decision 2008/911/EC is amended as follows: (1) in Annex I, the following substance is inserted after Thymus vulgaris L., Thymus zygis Loefl. ex L., aetheroleum: ‘ Vitis vinifera L., folium’ (2) in Annex II, the following is inserted after the entry on Thymus vulgaris L., Thymus zygis Loefl. ex L.: ‘COMMUNITY LIST ENTRY ON VITIS VINIFERA L., FOLIUM Scientific name of the plant Vitis vinifera L. Botanical family Vitaceae Herbal substance Grapevine leaf  ( 1 ) Common name of herbal substance in all EU official languages   BG (bălgarski): лоза, лист   CS (čeština): Červený list vinné révy   DA (dansk): Vinblad   DE (Deutsch): Rote Weinrebenblätter   EL (elliniká): Φύλλο Αμπέλου   EN (English): Grapevine leaf   ES (español): Vid, hoja de   ET (eesti keel): Viinapuu lehed   FI (suomi): Aitoviiniköynnös, lehti   FR (français): Feuille de vigne rouge   HU (magyar): Bortermő szőlő levél   IT (italiano): Vite, foglia   LT (lietuvių kalba): Tikrųjų vynmedžių lapai   LV (latviešu valoda): Īstā vīnkoka lapas   MT (malti): Werqa tad-dielja   NL (nederlands): Wijnstokblad   PL (polski): Liść winorośli właściwej   PT (português): Folha de videira   RO (română): Frunze de viță-de-vie   SK (slovenčina): List viniča   SL (slovenščina): List vinske trte   SV (svenska): Blad från vinranka   IS (íslenska): Vínviðarlauf   NO (norsk): Rød vinranke, blad Herbal preparation(s) Soft extract (2.5-4:1; extraction solvent water) European Pharmacopoeia monograph reference Not applicable Indication(s) Traditional herbal medicinal product to relieve symptoms of discomfort and heaviness of legs related to minor venous circulatory disturbances. The product is a traditional herbal medicinal product for use in specified indication exclusively based upon long-standing use. Type of tradition European Specified strength Please see “Specified posology”. Specified posology Adults and elderly Soft extract (2.5-4:1; extraction solvent water) in a cream base (10 g contain 282 mg soft extract). Apply a thin layer on the affected area 1-3 times daily. The use in children and adolescents under 18 years of age is not recommended (see section “Special warnings and precautions for use”). Route of administration Cutaneous use. Duration of use or any restrictions on the duration of use Adults and elderly The recommended duration of use is 4 weeks. If the symptoms persist longer than 2 weeks during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted. Any other information necessary for the safe use Contraindications Hypersensitivity to the active substance. Special warnings and precautions for use If there is inflammation of the skin, thrombophlebitis or subcutaneous induration, severe pain, ulcers, sudden swelling of one or both legs, cardiac or renal insufficiency, a doctor should be consulted. The product should not be used on broken skin, around the eyes or on mucous membranes. In the absence of sufficient safety data, the use in children and adolescents below 18 years of age is not recommended. Interactions with other medicinal products and other forms of interaction None reported. Pregnancy and lactation Safety during pregnancy and lactation has not been established. In the absence of sufficient data, the use during pregnancy and lactation is not recommended. Effects on ability to drive and use machines No studies on the effect on the ability to drive and use machines have been performed. Undesirable effects Contact allergy and/or hypersensitivity reactions of the skin (itching and erythema, urticaria) have been reported. The frequency is not known. If other adverse reactions not mentioned above occur, a doctor or a qualified health care practitioner should be consulted. Overdose No case of overdose has been reported. Pharmaceutical particulars (if necessary) Not applicable. Pharmacological effects or efficacy plausible on the basis of long-standing use and experience (if necessary for the safe use of the product) Not applicable. ( 1 )   The material complies with the monograph of the Pharmacopée Française X., 1996.’ " ( 1 )   The material complies with the monograph of the Pharmacopée Française X., 1996.’ ’

Other acts of the same type
Council Decision (EU) 2024/396 of 16 January 2024 on the conclusion, on behalf of the Union, of the Protocol on the implementation of the Fisheries Partnership Agreement between the European Community, on the one hand, and the Republic of Kiribati, on the other (2023-2028)Council Decision (EU) 2024/412 of 16 January 2024 on the signing, on behalf of the Union, and provisional application of the Protocol to the Euro-Mediterranean Agreement establishing an Association between the European Communities and their Member States, of the one part, and the Arab Republic of Egypt, of the other part, on a Framework Agreement between the European Union and the Arab Republic of Egypt on the general principles for the participation of the Arab Republic of Egypt in Union programmesCommission Implementing Decision (EU) 2024/237 of 15 January 2024 amending Implementing Decision (EU) 2019/450 as regards the publication of references of European Assessment Documents for three-layer polyethylene-based coating for corrosion protection of steel pipes and other construction productsCommission Implementing Decision (EU) 2024/241 of 15 January 2024 not approving Willaertia magna c2c maky as an active substance for use in biocidal products of product-type 11 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Decision (EU) 2024/222 of 12 January 2024 postponing the expiry date of the approval of boric acid for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCouncil Decision (CFSP) 2024/254 of 12 January 2024 concerning restrictive measures in view of the situation in GuatemalaCouncil Decision (CFSP) 2024/290 of 12 January 2024 amending Decision (CFSP) 2022/2319 concerning restrictive measures in view of the situation in HaitiCommission Implementing Decision (EU) 2024/201 of 10 January 2024 amending Implementing Decision (EU) 2022/1954 as regards harmonised standards for remote mechanical steering systems, permanently installed fuel systems and remote hydraulic steering systemsCommission Implementing Decision (EU) 2024/208 of 10 January 2024 postponing the expiry date of the approval of disodium tetraborate for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Decision (EU) 2024/258 of 10 January 2024 amending the Annex to Implementing Decision (EU) 2023/2447 concerning emergency measures in relation to outbreaks of highly pathogenic avian influenza in certain Member States (notified under document C(2024) 234)Commission Implementing Decision (EU) 2024/202 of 8 January 2024 amending Council Directive 2002/56/EC as regards the date laid down in Article 21(3) until which Member States are authorised to extend the validity of decisions concerning equivalence of seed potatoes from third countries (notified under document C(2024) 3)Council Implementing Decision (CFSP) 2024/215 of 4 January 2024 implementing Decision (CFSP) 2017/1775 concerning restrictive measures in view of the situation in Mali

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next